MARKET

ELUT

ELUT

Elutia Inc.
NASDAQ
0.8788
-0.0412
-4.48%
After Hours: 0.8500 -0.0288 -3.28% 19:59 11/12 EST
OPEN
0.9200
PREV CLOSE
0.9200
HIGH
0.9399
LOW
0.8642
VOLUME
83.19K
TURNOVER
--
52 WEEK HIGH
1.385
52 WEEK LOW
0.5000
MARKET CAP
39.02M
P/E (TTM)
0.6868
1D
5D
1M
3M
1Y
5Y
1D
Elutia’s High-Cost Avenue Loan Raises Liquidity Risks and Threatens Operational Stability
TipRanks · 1d ago
Weekly Report: what happened at ELUT last week (1102-1106)?
Weekly Report · 3d ago
Elutia (ELUT) Q3 2026 Earnings Call Transcript
The Motley Fool · 6d ago
Elutia reports Q3 results
Seeking Alpha · 6d ago
Elutia Inc. Reports Third Quarter 2026 Results and Plans NXT-41x FDA Submission
NASDAQ · 6d ago
Press Release: Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through Launch
Dow Jones · 11/05 21:17
Weekly Report: what happened at ELUT last week (1026-1030)?
Weekly Report · 11/02 09:19
Weekly Report: what happened at ELUT last week (1019-1023)?
Weekly Report · 10/26 09:19
More
About ELUT
Elutia Inc. is a commercial-stage company developing proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. Its cardiovascular biomatrix portfolio spans pericardial closure, intracardiac tissue repair, and vascular reconstruction. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. Its cardiovascular products are specifically designed to provide immediate structural support while promoting tissue regeneration, cellular infiltration, and natural integration over time. It is focused on developing NXT-41x, an antibiotic-eluting biomatrix designed to address post-operative infection. The NXT-41x product is designed to provide soft-tissue reinforcement while locally delivering antibiotics locally to inhibit bacterial colonization at the surgical site.

Webull offers Elutia Inc stock information, including NASDAQ: ELUT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELUT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELUT stock methods without spending real money on the virtual paper trading platform.